Envision Healthcare Corporation (EVHC) Downgraded to Equal Weight at Stephens
Stephens lowered shares of Envision Healthcare Corporation (NYSE:EVHC) from an overweight rating to an equal weight rating in a report published on Thursday morning. The brokerage currently has $32.00 price target on the stock.
Other analysts also recently issued reports about the company. Zacks Investment Research upgraded Envision Healthcare Corporation from a sell rating to a hold rating in a report on Friday, August 11th. Mizuho dropped their price objective on Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating for the company in a report on Wednesday, August 9th. BidaskClub downgraded Envision Healthcare Corporation from a sell rating to a strong sell rating in a report on Thursday, August 17th. Bank of America Corporation downgraded Envision Healthcare Corporation from a buy rating to a neutral rating and set a $32.00 price objective for the company. in a report on Thursday. Finally, Jefferies Group LLC set a $71.00 price objective on Envision Healthcare Corporation and gave the stock a buy rating in a report on Wednesday. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Envision Healthcare Corporation currently has an average rating of Buy and an average target price of $49.21.
Envision Healthcare Corporation (EVHC) traded down $0.21 during mid-day trading on Thursday, hitting $27.04. The stock had a trading volume of 4,795,013 shares, compared to its average volume of 5,488,916. The firm has a market cap of $3,267.14, a P/E ratio of 8.35, a price-to-earnings-growth ratio of 0.57 and a beta of 0.69. The company has a current ratio of 3.01, a quick ratio of 2.82 and a debt-to-equity ratio of 0.89. Envision Healthcare Corporation has a 1-year low of $26.56 and a 1-year high of $74.75.
Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company’s quarterly revenue was up 142.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.13 earnings per share. equities analysts forecast that Envision Healthcare Corporation will post 3.12 earnings per share for the current year.
Envision Healthcare Corporation declared that its board has authorized a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to purchase up to 4.5% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.
A number of large investors have recently bought and sold shares of the business. BNP Paribas Arbitrage SA boosted its position in Envision Healthcare Corporation by 51.2% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 71,960 shares of the company’s stock valued at $3,235,000 after buying an additional 24,366 shares during the last quarter. GHP Investment Advisors Inc. boosted its position in Envision Healthcare Corporation by 21.5% in the 3rd quarter. GHP Investment Advisors Inc. now owns 23,919 shares of the company’s stock valued at $1,075,000 after buying an additional 4,234 shares during the last quarter. Swiss National Bank boosted its position in Envision Healthcare Corporation by 1.2% in the 3rd quarter. Swiss National Bank now owns 432,916 shares of the company’s stock valued at $19,460,000 after buying an additional 5,200 shares during the last quarter. Principal Financial Group Inc. boosted its position in Envision Healthcare Corporation by 1.6% in the 3rd quarter. Principal Financial Group Inc. now owns 182,296 shares of the company’s stock valued at $8,194,000 after buying an additional 2,799 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its position in Envision Healthcare Corporation by 114.3% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 26,353 shares of the company’s stock valued at $1,185,000 after buying an additional 14,053 shares during the last quarter.
Envision Healthcare Corporation Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.